Opinion \ Manufacturers’ Group Pushes for Country-of-Origin Labeling, and Amazon Pushes Back
Greg Owens \ June 7, 2021 \ Industry Week The COOL bill would mandate prominent disclosure of where a product is produced, for all online
Amazon and other retailers oppose measure to require country-of-origin labeling for goods sold online
The proposal has bipartisan support in China-related legislation moving through the Senate By Jeanne Whalen and Abha Bhattarai May 27, 2021 Amazon and other retailers are
Senate Hearing On Medical Supplies: “US Companies No Longer Getting PPE Orders. It’s Mostly Going To China”
Here we go again. Textile companies that spent money on retooling to make masks and hospital gowns now losing to China dumping PPE in the U.S.
Senator Wyden Faces Obstacles To Permanent Clean Energy Tax Break Plan
Worried about climate change, Senator Wyden and the Democrats want to give cleantech and energy companies permanent tax breaks. He faces some serious opposition.
From Climate to China Dependency, Remapping Supply Chains Gains Traction Among Big Business
McKinsey has turned the corner on the Asia-centric model of globalization. It’s a “now-or-never” moment for US manufacturing. Here’s where CPA sees eye-to-eye.
Making The Case For Reshoring Critical Drugs, Where 90% Of Inputs Are In China’s Hands
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
Trade Blockage Another Example Why China Decoupling is Necessary
Recent shortages an example of America’s over-bearing dependence on Chinese supply chains. The time is now to take action to reverses this decades-long headwind to U.S. manufacturing and its labor force.
Senate Hearing on Pandemic Discusses Reshoring Pharma, PPE
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
China Dependent Companies Need to Prepare for Continued Supply Chain Changes
Lawyers from Wiley are telling their clients to prepare for ongoing supply disruptions due to Biden’s China policies.
Elizabeth Warren Gets it Right on Pharmaceutical Manufacturing
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
